Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Stage IIIC1 Cervical Cancer FIGO 2018 in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
MED e-care Healthcare Solutions
Shanxi Kangbao Pharmaceutical company
Agustin Sampietro
Fortuderm Ltd.
Pedro Currais, MD, Instituto Português de Oncologia de Lisboa
David Antoniucci
Diverse and Resilient
CEIP-A Lyon
Bangladesh College Of Physicians And Surgeons (BCPS)
Tim Van den Wyngaert
Comunicare Solutions SA
Hennepin Faculty Associates
Autonomic Technologies, Inc.
Foundation for Physical Medicine and Rehabilitation
Kneippsche Stiftungen
Matthew R Quigley
Malin Collin
The Danish National Rehabilitation Center for Neuromuscular Diseases
Suzanne Baron, MD
Alfonso X El Sabio University
View Full List
Medical Conditions
ST-segment Elevation Myocardial Infarction
Work Engagement
CACNA1C
Safety of Novel Curcumin Formulations
Severe Unilateral Sensorineural Hearing Loss
Therapeutic Patient Education
Functional Visual Loss
Irritation in Skin
Frontotemporal Dementia
Allergy Skin
Effect of Change in T1DM Glycemic Control
Primary Liver Cancers
Adult Patients in Need of High-energy Oral Nutritional Supplementation
Effusion Pleural
Prostate Nodule
Nitrate-depleted Dose
Familial Pulmonary Fibrosis
Overhead Athletes
Specific Learning Disorder
Hepatic Decompensation
View Full List
Drug Interventions
C1 Inhibitor Human
TBC3711
Platinum-Based Chemotherapy
Lithium Carbonate
ADI-PEG 20 plus Pem Cis
Cabozantinib
Amosartan
Pegylated Interferon
Timolol + LCP
AVB-620
Late Dinner tracer
Ropivacaine 0.2% Injectable Solution Infusion
Rasagiline Mesylate
S1
Nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)
Pertuzumab
Bacteriophage
Targeted drugs
CNTO 6785
Vit D
View Full List
CROs by country
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Belarus
Contract Research Organizations in Benin
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Germany
Contract Research Organizations in Indonesia
Contract Research Organizations in Lebanon
Contract Research Organizations in Madagascar
Contract Research Organizations in Philippines
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Tunisia
Contract Research Organizations in Ukraine
CRO list by country
CROs in Congo, DR of
ACROSS Global
SGS
All CROs in Congo, DR of
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe